Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.03
Delayed Data
As of Sep 23
 -0.0128 / -1.23%
Today’s Change
0.64
Today|||52-Week Range
1.97
-27.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.0K999.572.0K--
 
 
 
 
 
Operating ExpensesGross Income-2.0K-999.57-2.0K0.00
 
 
 
 
General Expenses472.0K394.8K743.9K602.5K
 
 
 
 
 
Other Operating Expenses-0.000.000.000.00
 
 
Research And Development68.0K133.9K333.9K233.2K
 
 
 
 
 
Total Operating Expenses474.0K395.8K745.9K602.5K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-474.0K-395.8K-745.9K-602.5K
 
 
 
 
 
Extraordinary Charge--0.00-1.6M0.00
 
 
Other Expenses53.2K-47.0K212.6K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-420.8K-442.8K-2.1M-577.5K
 
 
 
 
 
Discontinued Operations0.000.00-229.6K0.00
 
 
Net Income-420.8K-442.8K-2.4M-577.5K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.7M13.7M13.7M13.7M
 
 
 
 
 
Shares To Calculate EPS Diluted13.7M13.7M13.7M13.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.04---$0.04
 
 
 
 
EPS Diluted-$0.04-$0.04-$0.18-$0.04